About
Contact & Profiles
A5001060527
Research Areas
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Pancreatitis Pathology and Treatment
- Nuclear Structure and Function
- Dialysis and Renal Disease Management
- Dermatological and Skeletal Disorders
- Pregnancy and Medication Impact
- Parvovirus B19 Infection Studies
- Pharmacological Effects and Toxicity Studies
- Pharmaceutical studies and practices
- Immunodeficiency and Autoimmune Disorders
- Blood groups and transfusion
- Muscle and Compartmental Disorders
- Mitochondrial Function and Pathology
- Heterotopic Ossification and Related Conditions
- Renal Diseases and Glomerulopathies
- Metabolism and Genetic Disorders
- Platelet Disorders and Treatments
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- IgG4-Related and Inflammatory Diseases
- Central Venous Catheters and Hemodialysis
- Systemic Sclerosis and Related Diseases
- Cellular Mechanics and Interactions
- Parathyroid Disorders and Treatments
- Skin and Cellular Biology Research
- Connective tissue disorders research
Instituto de Investigación Biosanitaria de Granada
2011-2024
AA (secondary) amyloidosis is one of the most severe and uncommon complications several rheumatic disorders chronic infections such as tuberculosis (TB). Successful treatment depends on control underlying inflammatory process, what can lead to an improvement or a regression in organ dysfunction. If disorder persists, it has been reported some cases secondary diseases, that use biologic therapy so far only opportunity reduce development reverse established deposits. We report herein case...
10.3109/13506129.2011.613962
article
EN
Amyloid
2011-10-12
10.1016/j.nefro.2020.05.013
article
ES
cc-by-nc-nd
Nefrología
2020-09-14
10.1016/j.nefroe.2019.08.008
article
EN
cc-by-nc-nd
Nefrología (English Edition)
2020-07-01
10.1016/j.nefro.2022.07.001
article
ES
cc-by-nc-nd
Nefrología
2022-07-30
Coming Soon ...